You optimise the models, but who monitors the mind?
In multi-billion dollar environments, performance is lost at 3:14 PM, when cortisol spikes, flexibility drops, and flawed decisions feel rational.
94% of catastrophic trading anomalies trace back to human cognitive fatigue
Stress-induced tunnel vision reduces information processing capacity by 60%.
Traditional analytics measure the market. We measure the decision-maker
Meet the Team
-
Sophie Hascher, Co-Founder, CEO
Sophie is the CEO of NeuroWealth. With a background in neuroscience and cognitive performance, her work centres on the application of neurotechnology to high-stakes decision-making
-
Yazan Shaba, Co-founder, CTO
Yazan is the CTO of NeuroWealth. He leads the development of the company’s data architecture and machine learning systems, transforming complex neurophysiological signals into scalable, real-time performance analytics
“NeuroWealth helps investment professionals detect moments of cognitive vulnerability in real time, reducing costly decision errors by identifying when the brain is most at risk under pressure by using EEG and machine learning models”
$4.2B
Estimated Annual Loss to Cognitive Fatigue in Tier 1 Funds
15min
Average Warning Lead Time Before Critical Error
Zero
Acceptable Margin of Error in High-Frequency Execution
NeuroWealth is currently available by private invitation only. Pilot programs are strictly limited to qualifying institutions managing $1B+ AUM.